O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study

• B. Hajarizadeh,
• J. Grebely,
• M. Byrne,
• P. Marks,
• J. Amin,
• T. Butler,
• P. Vickerman,
• N.K. Martin,
• J.G. McHutchison,
• D.M. Brainard,
• C. Treloar,
• A.R. Lloyd,
• G.J. Dore

Affiliations

B. Hajarizadeh

Kirby Institute, UNSW Sydney, Sydney, Australia

J. Grebely

Kirby Institute, UNSW Sydney, Sydney, Australia

M. Byrne

Kirby Institute, UNSW Sydney, Sydney, Australia

P. Marks

Kirby Institute, UNSW Sydney, Sydney, Australia

J. Amin

Kirby Institute, UNSW Sydney, Sydney, Australia

T. Butler

Kirby Institute, UNSW Sydney, Sydney, Australia

P. Vickerman

School of Social and Community Medicine, University of Bristol, UK

N.K. Martin

School of Social and Community Medicine, University of Bristol, UK; Division of Global Public Health, University of California San Diego, CA, USA

J.G. McHutchison

Gilead Sciences, Inc., Foster City, CA, USA

D.M. Brainard

Gilead Sciences, Inc., Foster City, CA, USA

C. Treloar

Centre for Social Research in Health, UNSW Sydney, Sydney, Australia

A.R. Lloyd

Kirby Institute, UNSW Sydney, Sydney, Australia; Justice Health and Forensic Mental Health Network, NSW, Australia

G.J. Dore

Kirby Institute, UNSW Sydney, Sydney, Australia